In contrast, T1D subjects with lower concentrations of IL-17 initial levels of IL-17 correlated negatively with HbA1c (p < 0.05) and value of c-peptide at 24th month of the therapy (p < 0.05). The gene discussed is IL17A; the disease is type 1 diabetes mellitus.